Skip to content

Early Double Sequential Defibrillation in Out-of-hospital Cardiac Arrest

A Pilot Study Assessing Feasibility of a Randomized Trial Comparing the Effect of Early Double Sequential Defibrillation as Soon as Possible in OHCA With a Shockable Rhythm (VT/VF) Compared to Standard Defibrillation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06447805
Acronym
DOUBLE-D
Enrollment
40
Registered
2024-06-07
Start date
2024-08-01
Completion date
2025-09-23
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Fibrillation, Ventricular, Sudden Cardiac Arrest, Sudden Cardiac Death

Keywords

Cardiopulmonary resuscitation, Defibrillation, Double sequential defibrillation

Brief summary

Some of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation. The survival decreases with number of defibrillations required to terminate VF/VT. In 2022, one prospective cluster randomized trial showed increased survival among (OHCA) patients in refractory VF using Double Sequential Defibrillation (DSD). To evaluate feasibility and safety this randomized pilot trial will compare the effect of double defibrillation strategy initiated as soon as possible after the first defibrillation with continued resuscitation using standard defibrillation, in patients with Out of Hospital Cardiac arrest (OHCA). The results from this pilot trial will form the basis for design of a larger multicenter survival study.

Detailed description

The Dubbel-D study is an academic, investigator initiated, open-label pilot study with a randomized controlled trial (RCT) design conducted in the prehospital emergency medical services, i.e. ambulance organizations. The trial will be conducted by participating ambulance units attending OHCA´s. These units will perform screening for inclusion, randomization, intervention or control treatment and initial follow-up. In all cases of OHCA a defibrillator should always be attached with the standard pad placement, anterio-lateral (A-L) position first. This is in accordance with standard of care. If there is VT/VF or an automated external defibrillator (AED) suggests defibrillation, defibrillation should be performed, and immediate chest compressions resumed. Thereafter, the patient can be screened for inclusion. If two study specific defibrillators (Corpulse 3) on site and no exclusion criteria (age below 18 years, obvious pregnancy, known preexisting Do Not Attempt Resuscitation order) the patient can be included and randomized. Randomization will be performed by drawing a scratch-card with concealed allocation that will be stored with the EMS defibrillators. All scratch-cards will be pre-randomized in a 3:1 ratio in blocks consisting of 4-8-12 and stratified by region and ambulance provider. If the patient is randomized to the intervention group, the ambulance crew team will apply the second defibrillator with electrodes placed in the anterio-posterior (A-P) position as soon as possible. Defibrillation is performed by one person defibrillating both defibrillators in a sequential manner Double Sequential Defibrillation (DSD). All consecutive defibrillations will thereafter be performed with the DSD strategy until ROSC, termination of resuscitation or decision to move the patient to hospital. If randomized to the control group, the ambulance crew team will continue Advanced Life Support (ACLS) in accordance with standard of care. Defibrillation is performed with standard electrode placement (A-L position) using a single defibrillator. If an AED is the first defibrillator attached to the patient, the ambulance crew should shift from an AED to their own manual defibrillator, but the mode of defibrillation should remain in A-L position and only one defibrillator should be used for each defibrillation and continue until ROSC, termination of resuscitation or decision to move the patient to hospital.

Interventions

DEVICEDouble Sequential Defibrillation (DSD)

The second defibrillator will be applyed with electrodes placed in the A-P position

Standard defibrillation uning one defibrillator

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Academic, investigator initiated, open-label pilot study with a randomized controlled trial (RCT) design and 3:1 allocation (3 intervention: 1 standard).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Out-of-Hospital patients with Ventricular Fibrillation/ Ventricular Tachycardia at rhythm analysis after ambulance arrival and at least one defibrillation performed in standard (Antero-Lateral) position

Exclusion criteria

* Age below 18 years * Obvious pregnancy * Known preexisting Do Not Attempt Resuscitation order

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of early double sequential external defibrillation (DSD)day 1Number of EMS defibrillations prior to randomization (target \> 80% before third defibrillation)
Adherence to double sequential external defibrillation (DSD)day 1Among patients randomized to DSD, proportion that received DSD (target \> 80%)
Cross-overday 1Among patients randomized to standard, proportion that received DSD (target \< 10%)
Feasibility of double sequential external defibrillation (DSD)day 1Proportion of eligible patients included and randomized (target \> 80%)
Safety of double sequential external defibrillationday 1Major adverse events (e.g. defibrillator malfunction)
Safety of CPR during double sequential external defibrillationday 1Chest compression fraction (hands off time during CPR, target \> 80% in both groups)

Secondary

MeasureTime frameDescription
Neurological function at 30 daysday 30Neurological function (modified Rankin Scale, mRS 1-6, and Cerebral Performance Category, CPC 1-5) at 30 days
30 day survivalday 30Survival at 30 days
Neurological function and Health related Quality of life at 90 and 180 daysday 90 and 180Neurological function (modifiied Rankin Scale and Cerebral Performance Category) and Health-related Quality of life at 90 and 180 days (CPC 1-5, mRS 1-6)
Return of spontaneous circulation (ROSC)day 1Proportion of patients with sustained return of spontaneous circulation (ROSC) at hospital arrival
Number of defibrillations to sustained ROSCday 1Total number of defibrillations to sustained ROSC
Survival to hospital admissionday 1Pateint is admitted to hospital alive
Survival to dischargeday 1-180Survival to hospital discharge

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026